Those results are also supported by Zhang et al. research, supporting that upregulation of GITR coincides with enhanced proliferation of CD4+CD25+ Treg populations as well as concurrent upregulation of CTLA4 in patients with HCC [84,86]. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.